Cargando…
Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887310/ https://www.ncbi.nlm.nih.gov/pubmed/24300970 http://dx.doi.org/10.1038/bjc.2013.736 |
| _version_ | 1782479003029864448 |
|---|---|
| author | Shamash, J Sarker, S-J |
| author_facet | Shamash, J Sarker, S-J |
| author_sort | Shamash, J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3887310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38873102014-01-10 Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' Shamash, J Sarker, S-J Br J Cancer Letter to the Editor Nature Publishing Group 2014-01-07 2013-12-03 /pmc/articles/PMC3887310/ /pubmed/24300970 http://dx.doi.org/10.1038/bjc.2013.736 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Letter to the Editor Shamash, J Sarker, S-J Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title | Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_full | Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_fullStr | Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_full_unstemmed | Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_short | Comment on ‘Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| title_sort | comment on ‘anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer' |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3887310/ https://www.ncbi.nlm.nih.gov/pubmed/24300970 http://dx.doi.org/10.1038/bjc.2013.736 |
| work_keys_str_mv | AT shamashj commentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer AT sarkersj commentonantitumouractivityofabirateroneanddiethylstilboestrolwhenadministeredsequentiallytomenwithcastrationresistantprostatecancer |